Clinical Trials Browser

Breast Neoplasms, Male × Neoadjuvant Therapy × 1 year × Clear all

NCT03387553 2026-05-07

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Breast Neoplasms, Male